Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF ) Freely available
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (6)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Matsuzaki, S.
Right arrow Articles by Okamura, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Matsuzaki, S.
Right arrow Articles by Okamura, K.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol. 16, No. 5, 945-948, May 2001
© 2001 European Society of Human Reproduction and Embryology

Erythropoietin concentrations are elevated in the peritoneal fluid of women with endometriosis

Sachiko Matsuzaki,1, Takashi Murakami, Shigeki Uehara, Rei Yokomizo, Takahiro Noda, Yoshitaka Kimura and Kunihiro Okamura

Department of Obstetrics & Gynecology, Tohoku University School of Medicine, Sendai, Japan

Erythropoietin (Epo) is an important regulator of erythropoiesis and stimulates the proliferation of early erythroid precursors as well as the differentiation of late erythroid precursors of the erythroid lineage. However, recent studies have indicated that Epo also has angiogenic properties and plays an important role in the oestrogen-dependent cyclical angiogenesis within the mouse uterus. It was therefore postulated that Epo may be an important angiogenic factor in endometriosis. In order to address this hypothesis the concentration of Epo in peritoneal fluid (PF) was determined in patients with or without endometriosis. PF was collected from patients with endometriosis (n = 42) or without endometriosis (n = 18). Detectable concentrations of Epo were found in all PF samples analysed. The concentration of Epo in PF from patients with endometriosis was significantly higher than that in the control group (13.1 ± 1.2 mIU/ml versus 7.2 ± 0.7 mIU/ml, mean ± SE respectively, P < 0.01). Furthermore, in patients with endometriosis the Epo concentrations in PF from patients with stage I disease (n = 17, 16.6 ± 3.0 mIU/ml) were significantly higher than those with stage II (n = 8, 10.7 ± 1.2 mIU/ml, P < 0.03), III (n = 13, 8.4 ± 1.0 mIU/ml, P < 0.01), IV disease (n = 7, 7.5 ± 1.0 mIU/ml, P < 0.01). These data suggest that Epo may play a role in the pathogenesis of endometriosis particularly in the initiation of the disease.

Key words: angiogenesis/endometriosis/erythropoietin/peritoneal fluid

1 To whom correspondence should be addressed at: Department of Obstetrics & Gynecology, Tohoku University School of Medicine, 1–1, Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan. E-mail: matsuzaki{at}ob-gy.med.tohoku.ac.jp


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Hum Reprod UpdateHome page
M. W. Laschke and M. D. Menger
In vitro and in vivo approaches to study angiogenesis in the pathophysiology and therapy of endometriosis
Hum. Reprod. Update, July 1, 2007; 13(4): 331 - 342.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
S. Matsuzaki, M. Canis, R. Yokomizo, N. Yaegashi, M. A. Bruhat, and K. Okamura
Expression of erythropoietin and erythropoietin receptor in peritoneal endometriosis
Hum. Reprod., January 1, 2003; 18(1): 152 - 166.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.